Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover

Abstract excerpt

Sclerosteosis is a rare bone sclerosing dysplasia, caused by loss-of-function mutations in the SOST gene, encoding sclerostin, a negative regulator of bone formation. The purpose of this study was to determine how the lack of sclerostin affects bone turnover in patients with sclerosteosis and to assess whether sclerostin synthesis is decreased in carriers of the SOST mutation and, if so, to what extent this would...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alkaline Phosphatase Research Studies
• Share to Bone health and osteoporosis research
• Share to Bone Metabolism and Diseases